MABS430MI

MilliporeSigma™ Mouse anti-Mcpip1, Clone: 2H8.2,

Manufacturer: MilliporeSigma™

Select a Size

Pack Size SKU Availability Price
Each of 1 MABS430MI-Each-of-1 In Stock ₹ 38,958.86

MABS430MI - Each of 1

₹ 38,958.86

In Stock

Quantity

1

Base Price: ₹ 38,958.86

GST (18%): ₹ 7,012.595

Total Price: ₹ 45,971.455

Antigen

Mcpip1

Classification

Monoclonal

Formulation

Purified mouse monoclonal IgG2aκ in buffer containing 0.1M Tris-Glycine (pH 7.4), 150mM NaCl with 0.05% sodium azide.

Gene Symbols

ZC3H12A; MCPIP; MCPIP1

Immunogen

GST-tagged recombinant protein corresponding to human Mcpip1.

Quantity

100 μg

Research Discipline

Signaling

Gene ID (Entrez)

NP_079355

Content And Storage

Stable for one year at 2°C to 8°C from date of receipt.

Isotype

IgG2a κ

Applications

Immunocytochemistry, Immunohistochemistry (Paraffin)

Clone

2H8.2

Gene Accession No.

Q5D1E8

Host Species

Mouse

Purification Method

Protein G Purified

Regulatory Status

RUO

Primary or Secondary

Primary

Target Species

Human

Form

Purified

Related Products

Img

MilliporeSigma™

MABS186MI

--

Img

MilliporeSigma™

MABC269MI

--

Img

MilliporeSigma™

MABS508MI

--

Img

MilliporeSigma™

MABS518MI

--

Img

MilliporeSigma™

MABN319MI

--

Img

MilliporeSigma™

MABC565MI

--

Img

MilliporeSigma™

MABC663MI

--

Img

MilliporeSigma™

MABS1156MI

--

Description

  • Specifically detects Mcpip1 clone: 2H8.2 in Human samples, and it is validated for Immunocytochemistry, Immunohistochemistry (Paraffin) MCP-induced protein 1 (also known as ribonuclease ZC3H12A, Zinc finger CCCH domain-containing protein 12A) is encoded by the ZC3H12A gene in human (also known as dJ423B22.1, MCPIP, MCPIP1)
  • It belongs to the 4-member CCCH-zinc finger protein family (MCPIP1/2/3/4) that act as negative regulators in macrophage activation (PMID 18178554)
  • MCPIP1 in particular is involved in immune response downregulation upon LPS treatment by targeting IL-6 and IL-12b with its RNase activity (PMID 22561375)
  • MCPIP1 expresssion by MCP-1 treatment is reported to promote angiogenesis in human umbilical vein endothelial cell (HUVEC) cultures, while causing apoptotic cell death in cardiac myocytes (PMID 18364357 & 16574901).